JPMorgan Chase Analyst Michael Weinstein believes
that 2014 will be good to the medtech sector. This week, the JPMorgan analyst
published a research where he says to expect the medtech sector to grow 4.2%
this year, up 0.8% from 2013.
“We see growth broadly accelerating in 2014-2015 as
an industry that bottomed in 2011-2012 sees the benefits of new products, new
markets, and small to mid- sized M&A. This is particularly true in
cardiovascular devices, where we see growth accelerating at all three large cap
names and ample room for innovation in small-cap, emerging growth companies –
both public and private.”
Michael Weinstein
No comments:
Post a Comment